Facchini Peter J. 4
4 · Enveric Biosciences, Inc. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Enveric (ENVB) CIO Peter J. Facchini Receives 25,000 RSUs
What Happened Peter J. Facchini, Chief Innovation Officer of Enveric Biosciences, was granted 25,000 restricted stock units (RSUs) on June 1, 2026. The award was recorded at $0.00 per share (no cash paid at grant); each vested RSU converts to one share of common stock when it vests.
Key Details
- Transaction date: 2026-06-01; Form 4 filed 2026-06-03 (timely filing).
- Transaction type/code: Award/Grant (A); 25,000 RSUs granted at $0.00.
- Vesting: Per the company’s 2020 Long-Term Incentive Plan — 1/4 vests at one year, then 1/36 of the grant vests each month thereafter, with remaining units vesting on the fourth anniversary; vesting conditioned on continued employment (see footnote F1).
- Shares owned after transaction: Not specified in the filing.
- Adjustment note: Amounts have been adjusted for a 12-for-1 reverse stock split effective Oct 28, 2025 (see footnote F2).
Context RSUs are a form of equity compensation that convert into common stock only as they vest; they are not an immediate open-market purchase or sale and do not necessarily indicate a near-term change in share ownership. This grant was a routine compensation award to an executive, filed promptly with the SEC.
Insider Transaction Report
Form 4
Facchini Peter J.
Chief Innovation Officer
Transactions
- Award
Common Stock
[F1][F2]2026-06-01+25,000→ 27,755 total
Footnotes (2)
- [F1]Represents the restricted stock units (the "RSUs") granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan, as amended. For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock. One-fourth of the RSUs will vest upon the one-year anniversary of the date of issuance. An additional one-thirty-sixth of the RSUs will vest each month following the first vesting date. Any remaining RSUs will vest on the fourth anniversary of the date of issuance. Vesting is conditioned upon continued employment by the Company.
- [F2]On October 28, 2025, the common stock of the Company began trading on a split-adjusted basis, pursuant to which every 12 shares of issued and outstanding common stock were reclassified as one share of common stock (the "Reverse Stock Split"). The amount of securities reported in this Form 4 has been adjusted to reflect the Reverse Stock Split.
Signature
/s/ Peter J. Facchini|2026-06-03